Escitalopram

Preview FDA label, Jubilant Cadista Pharmaceuticals Inc., oral, effective 2026-07-17. Full label on DailyMed

Quoted from the FDA label. Product labels differ by manufacturer and change over time; confirm against the label for the product you are using. Not yet reviewed by a ClinDose pharmacist.

Dosing in kidney impairment

Renal Impairment Pharmacokinetics of escitalopram in patients with a creatinine clearance less than 20 mL/minute has not been evaluated. No dosage adjustment is necessary for patients with mild or moderate renal impairment [see Dosage and Administration, Clinical Pharmacology] .

Dosing in liver impairment

Hepatic Impairment Increased citalopram exposure occurs in patients with hepatic impairment [see Clinical Pharmacology] . The recommended dosage of ESCITALOPRAM in patients with hepatic impairment is 10 mg daily [see Dosage and Administration] .

Preparation and administration

Administration Information Administer escitalopram tablets orally once daily, in the morning or evening, with or without food.